Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

11-18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/05/24	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Market Cap	519K 455K 419K 393K 736K 48.96M 752K 5.04M 1.95M 24.2M 1.95M 1.91M 83.9M	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	22.05M 19.33M 17.82M 16.68M 31.28M 2.08B 31.93M 214M 82.88M 1.03B 82.79M 80.98M 3.56B	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

11-18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/05/24	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/04/24	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
31/03/24	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
14/11/23	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
04/10/23	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
01/10/23	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
29/09/23	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
15/08/23	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
01/08/23	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
09/07/23	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
09/07/23	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
15/06/23	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

11-18	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
16/05/24	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
16/05/24	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
05/10/23	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
02/10/23	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+7.13%	+9.97%	+55.80%	+163.38%	1,077B
JOHNSON & JOHNSON	+3.99%	+11.50%	+67.09%	+56.27%	613B
ABBVIE INC.	+4.20%	+17.03%	+38.97%	+91.19%	448B
ROCHE HOLDING AG	+0.99%	+4.85%	+28.17%	+22.04%	332B
ASTRAZENECA PLC	+1.82%	+8.19%	+40.04%	+27.45%	293B
NOVARTIS AG	+0.22%	+6.75%	+31.30%	+42.64%	286B
NOVO NORDISK A/S	+0.73%	+8.53%	-27.33%	-40.29%	215B
AMGEN INC.	+1.56%	+6.14%	+29.30%	+61.91%	193B
GILEAD SCIENCES, INC.	+3.26%	+3.33%	+15.55%	+67.87%	159B
Average	+2.66%	+8.48%	+30.99%	+54.72%	401.79B
Weighted average by Cap.	+3.85%	+9.65%	+41.75%	+81.02%

Exactus Inc Share Price OTC Bulletin Board

Stocks

US30066P1021

Pharmaceuticals

Valuation: Exactus Inc

Latest news : Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

	2022	2023
Net sales	1.63M 1.43M 1.31M 1.23M 2.31M 153M 2.36M 15.8M 6.12M 75.85M 6.11M 5.98M 263M	2.38M 2.09M 1.93M 1.8M 3.38M 225M 3.45M 23.17M 8.96M 111M 8.96M 8.76M 386M
Net income	-9.14M -8.02M -7.39M -6.92M -12.97M -862M -13.24M -88.81M -34.37M -426M -34.33M -33.58M -1.48B	-8.02M -7.03M -6.48M -6.06M -11.37M -756M -11.61M -77.86M -30.13M -374M -30.1M -29.44M -1.3B
Net Debt	17.85M 15.65M 14.43M 13.51M 25.33M 1.68B 25.86M 173M 67.11M 832M 67.04M 65.58M 2.89B	21.53M 18.88M 17.4M 16.29M 30.55M 2.03B 31.18M 209M 80.92M 1B 80.84M 79.08M 3.48B